Defunct Company
Total Trials
37
As Lead Sponsor
30
As Collaborator
7
Total Enrollment
9,827
NCT00224094
A Comparison of Patch vs. Pill Estrogen Therapy on Testosterone Levels and Thyroid Tests in Menopausal Women
Phase: Phase 4
Role: Lead Sponsor
Start: Jan 31, 2002
Completion: Not specified
NCT00224068
Effect of Iron Therapy as an Adjunct to Epoetin Alfa in the Anemia of Cancer Chemotherapy
Start: May 31, 2002
Completion: Dec 31, 2003
NCT02749825
Comparison of Trelstar Versus Lupron or Zoladex in Advanced Prostate Cancer
Role: Collaborator
Start: Sep 30, 2002
Completion: Jul 31, 2006
NCT00224003
Study of the Safety and Efficacy of Ferrlecit® Maintenance Dosing in Pediatric Hemodialysis Patients
Start: Apr 30, 2003
Completion: Feb 28, 2005
NCT00224042
Effect of Ferrlecit® Versus Oral Iron on Iron Deficient Chronic Kidney Disease (CKD) Patients Receiving Erythropoietic Agents
NCT00224055
Effect of Ferrlecit® Versus Oral Iron on Iron Deficient Chronic Kidney Disease (CKD) Patients
Completion: Sep 30, 2004
NCT00161304
Study to Determine the Effects of Testosterone Replacement Therapy in Aging Men With Androgen Deficiency
Phase: Phase 2/3
Completion: Nov 30, 2004
NCT00223964
Study of the Efficacy of Two Doses of Ferrlecit in the Treatment of Iron Deficiency in Pediatric Hemodialysis Patients
Start: Jun 30, 2003
NCT00124514
Triptorelin for Ovary Protection in Childhood Onset Lupus
Phase: Phase 2
Completion: Mar 31, 2014
NCT00223977
2 Doses of Ferrlecit Versus Oral Iron to Treat Iron-deficiency Anemia in Peritoneal Dialysis Patients.
Start: Dec 31, 2003
Completion: Feb 29, 2008
NCT00224146
Transdermal (TDS) Oxybutynin (Oxytrol(r)) in Overactive Bladder
Start: May 31, 2004
Completion: May 31, 2005
NCT00224081
DRIVE Trial (Dialysis Patients' Response to Intravenous [IV] Iron With Elevated Ferritin)
Start: Sep 30, 2004
NCT00224016
Safety and Efficacy Study of Transdermal Oxybutynin to Treat Overactive Bladder With a Neurological Condition
Start: Dec 31, 2004
Completion: Sep 30, 2008
NCT00224029
A Study Evaluating Oxybutynin in Patients With Neurogenic Overactive Bladder Associated With a Neurological Condition
Completion: May 31, 2008
NCT00224107
A New Drug for Benign Prostatic Hyperplasia (BPH) Compared With Placebo
Phase: Phase 3
Start: May 31, 2005
Completion: Aug 31, 2006
NCT00224120
Completion: May 31, 2006
NCT01044706
Bioequivalence Study of Bicalutamide 50 mg Tablet and Casodex® 50 mg Tablet in Healthy Subjects Under Fed Conditions
Phase: Phase 1
Completion: Jul 31, 2005
NCT00178282
Low-Intensity Physical Therapy for Prevention of Pre and Postpartum Urinary Incontinence
Phase: N/A
Start: Jun 30, 2005
Completion: Oct 31, 2007
NCT00224133
The Evaluation of the Safety of a New Drug for Benign Prostatic Hyperplasia Used for 9 Months
Start: Sep 30, 2005
Completion: Apr 30, 2007
NCT00350636
A Comparison of a New Drug to Treat Overactive Bladder vs. Placebo
Start: Jun 30, 2006
Completion: May 31, 2007
NCT00354692
Effect of Two Iron Preparations on Protein in the Urine
NCT00527917
A Pilot Clinical Investigation of the Efficacy and Safety of Uracyst® Versus Placebo in Patients With Interstitial Cystitis/Painful Bladder Syndrome.
Start: Sep 30, 2007
NCT00534144
Comparison Between Effects of Two Iron Preparations on Protein in the Urine
Completion: Nov 30, 2008
NCT00740779
Use of Silodosin to Treat Moderate to Severe Abacterial Chronic Prostatitis/Chronic Pelvic Pain Syndrome.
Start: Sep 30, 2008
Completion: Oct 31, 2009
NCT00752141
Cognitive Effects of Oral Oxybutynin and Oxybutynin Chloride Topical Gel in Older Volunteers
NCT00793819
A Study of Silodosin 8 mg Daily for the Treatment of Nocturia in Men With Benign Prostatic Hyperplasia
Start: Jan 31, 2009
NCT00926926
Effects of Oxybutynin Topical Gel on Gastric Emptying
Start: Jun 30, 2009
Completion: Jul 31, 2009
NCT00919113
Efficacy and Safety Study of Uracyst to Treat Interstitial Cystitis/Painful Bladder Syndrome
Start: Jul 31, 2009
Completion: Dec 31, 2010
NCT01104246
Dose Titration Investigation of the Pharmacokinetics of Testosterone Transdermal Systems in Hypogonadal Men
Start: Apr 30, 2010
Completion: Sep 30, 2010
NCT01140217
Efficacy and Safety Study of Norethindrone Acetate Transdermal Delivery System in Contraception
Start: May 31, 2010
Completion: Mar 31, 2012
NCT01144949
Study of Silodosin to Facilitate Passage of Urinary Stones
Start: Jun 30, 2010
Completion: Jul 31, 2012
NCT01161563
Randomized Crossover Trial to Assess the Tolerability of Gonadotropin Releasing Hormone (GnRH) Analogue Administration
Start: Jul 31, 2010
Completion: Apr 30, 2011
NCT01323140
Pharmacokinetics, Metabolism, Efficacy, and Safety Study of Two Testosterone Matrix Transdermal Systems
Start: Apr 30, 2011
Completion: Jul 31, 2011
NCT01513954
Examination of Serum Progesterone Levels in an IVF Population Following Two Types of Egg Aspiration
Start: Jan 31, 2012
Completion: Jun 30, 2013
NCT01553123
Efficacy and Safety Study of Ulipristal Acetate in Females With Anemia Associated With Uterine Leiomyoma
Start: Apr 30, 2012
Completion: Dec 31, 2013
NCT03440359
Vaginal Progesterone Supplementation in Women With PCOS Undergoing Ovulation Induction With Letrozole
Start: Jul 6, 2012
Completion: Dec 30, 2017
NCT02193139
Safety and Efficacy of an Anticholinergic Agent for Treatment of Primary Axillary Hyperhidrosis
Start: Dec 31, 2013
Completion: Jun 30, 2014